Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

for
Severe Hypertriglyceridemia
Location: Montreal, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06880770

Phase3, Recruiting

Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 Diabetes

for
Type 1 Diabetes
Location: Montreal
Sponsor: Institut de Recherches Cliniques de Montreal

Sex: All

Age: 18+

Code: NCT06683391

Recruiting

The Efficacy of Intra-articular Triamcinolone Acetonide 5mg vs. 10 mg vs. 40 mg in Patients With Knee Osteoarthritis

for
Primary Gonarthrosis
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 50+

Code: NCT05806021

Recruiting

Cooperative Huntington's Observational Research Trial

for
Huntington Disease
Location: Montreal, Albany NY, Boston MA, Rochester NY,
Sponsor: HP Therapeutics Foundation

Sex: All

Age: 0+

Code: NCT00313495

Recruiting

CANadian Clinical Evaluation of SpiderFlash Arrhythmia DETECTion in SpiderFlash™ Device

for
Arrhythmias, Cardiac
Location: Montreal, Sherbrooke, Edmonton
Sponsor: Sorin Group Canada

Sex: All

Age: 0+

Code: NCT01218763

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

for
Kidney Failure, Chronic, Hyperphosphatemia
Location: Montreal, Longueuil, Sherbrooke, Ottawa, Quebec,
Sponsor: The University of Queensland

Sex: All

Age: 18+

Code: NCT03573089

Recruiting

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

for
Atrial Fibrillation, Stroke, Bleeding
Location: Montreal, Burlington VT, Quebec, Lebanon NH,
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT04045665

Phase3, Recruiting
New

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

for
Sjögren's Disease
Location: Sherbrooke, Tampa FL, Oklahoma City OK, Bellaire TX
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07737743

Phase2, Recruiting

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

for
Prostate Cancer
Location: Montreal, Hartford CT, The Bronx NY, Pittsburgh PA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05803941

Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Montreal, Ottawa, Quebec, Syracuse NY, Boston MA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase3, Recruiting

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

for
Aortic Stenosis
Location: Montreal, Quebec, Ottawa, Albany NY, Boston MA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT05646381

Phase2, Recruiting

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

for
Solid Tumor
Location: Montreal, New York NY, Toronto, London, Pittsburgh PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04939610

Phase1, Phase2, Recruiting

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

for
IC-MPGN
Location: Montreal, Boston MA, Toronto, Etobicoke, New York NY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 60

Code: NCT05755386

Phase3, Recruiting

CAR-T Long Term Follow Up (LTFU) Study

for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Montreal, Boston MA, Toronto, Hamilton, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT02445222

Phase3, Recruiting

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Montreal, Boston MA, Toronto, Grand Rapids MI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06562192

Phase1, Recruiting

Asciminib Roll-over Study

for
Chronic Myelogenous Leukemia,
Location: Montreal, New York NY, Ann Arbor MI, Milwaukee WI,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 7 - 70+

Code: NCT04877522

Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Montreal, Sherbrooke, Ottawa, Levis, Quebec,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase3, Recruiting

A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation

for
Atrial Fibrillation
Location: Montreal, Quebec, Sherbrooke, Newmarket, Toronto,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07217067

Phase2, Recruiting

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Location: Montreal, Durham NC, Myrtle Beach SC, Iowa City IA,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07190300

Phase1, Phase2, Recruiting

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

for
Small Cell Lung Carcinoma,
Location: Montreal, Boston MA, Royal Oak MI, Iowa City IA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07006727

Phase1, Recruiting